Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 646.54M | 621.40M | 647.15M | 639.65M | 556.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 646.54M | 621.40M | 647.15M | 639.65M | 556.06M |
| Cost of Revenue | 570.83M | 540.71M | 540.30M | 535.55M | 454.43M |
| Gross Profit | 75.71M | 80.69M | 106.84M | 104.11M | 101.63M |
| SG&A Expenses | 47.00M | 67.06M | 67.52M | 68.78M | 44.79M |
| Depreciation & Amortization | 29.30M | 29.70M | 29.87M | 29.50M | 29.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 647.13M | 637.47M | 637.69M | 633.83M | 528.82M |
| Operating Income | -585.00K | -16.07M | 9.46M | 5.83M | 27.23M |
| Income Before Tax | -23.92M | -23.76M | 1.36M | -16.72M | -48.07M |
| Income Tax Expenses | -1.12M | -619.00K | -238.00K | 565.00K | -14.66M |
| Earnings from Continuing Operations | -22.80M | -23.14M | 1.60M | -17.28M | -33.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.80M | -23.14M | 1.60M | -17.28M | -33.41M |
| EBIT | -585.00K | -16.07M | 9.46M | 5.83M | 27.23M |
| EBITDA | 44.82M | 7.33M | 32.63M | 29.03M | 50.24M |
| EPS Basic | -0.27 | -0.27 | -0.06 | -0.22 | -0.36 |
| Normalized Basic EPS | -0.03 | -0.13 | 0.02 | 0.01 | 0.12 |
| EPS Diluted | -0.27 | -0.27 | -0.06 | -0.22 | -0.36 |
| Normalized Diluted EPS | -0.03 | -0.13 | 0.02 | 0.01 | 0.12 |
| Average Basic Shares Outstanding | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M |
| Average Diluted Shares Outstanding | 115.03M | 114.86M | 114.69M | 114.14M | 113.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -21.08% | -22.19% | 317.48% | -29.39% | -15.45% |
